Louisiana Record

Thursday, December 12, 2019

GAINSBURGH BENJAMIN DAVID MEUNIER: Settlement Reached Resolving Xarelto Multidistrict Litigation Claims

By Press release submission | Apr 15, 2019

Law money 12

Gainsburgh, Benjamin, David, Meunier issued the following announcement on April 9.

Our firm--which, through its partner Gerald Meunier as Co-Liaison Counsel, had a leadership role on behalf of plaintiffs--is pleased to announce that the makers of the popular blood-thinner Xarelto® have agreed to a $775,000,000 settlement to resolve litigation by patients who suffered bleeding injuries after taking the prescription drug.

According to the agreement announced on March 25, 2019, approximately 25,000 claims filed against Bayer Healthcare (OTC: BAYR) and Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson (NYSE: JNJ), now will be resolved. These claims include cases in federal and state courts.

"This is a fair resolution for thousands of consumers who have substantial claims," says Mr. Meunier. "We appreciate both the hard work of plaintiffs' counsel and the guiding role played by federal judge Eldon E. Fallon in overseeing the federal litigation here in New Orleans."

Under the settlement agreement, a Claims Administrator and two Special Masters will be retained to manage the settlement process and will be responsible for determining how funds will be allocated to those who are entitled to payment. It is expected that this process will continue throughout the remainder of 2019.

Original source can be found here.

Want to get notified whenever we write about Gainsburgh, Benjamin, David, Meunier & ?

Sign-up Next time we write about Gainsburgh, Benjamin, David, Meunier &, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

Gainsburgh, Benjamin, David, Meunier &